Skip to content
The Nexus
DossierENTITY

gene editing

Coverage of gene editing in the Nexus archive.

Earliest in view: Apr 10 · 14:12 UTCMost recent: Jun 17 · 06:10 UTC
Co-mentioned in this coverage
Recent coverage
  • SCIENCEJun 17 · 06:10 UTCEURACTIV
    HARVEST: Showdown day for gene editing rules

    The article discusses a critical day for gene editing regulations, focusing on topics including seeds, CMO, budget, and livestock. The showdown highlights ongoing debates or decisions related to these areas.

  • POLITICSJun 16 · 06:53 UTCEURACTIV
    HARVEST: Budget talks heat up

    Budget discussions related to agriculture are intensifying, with topics including gene editing, seeds, and the Common Agricultural Policy (CAP). The article highlights ongoing negotiations in this sector.

  • SCIENCEJun 11 · 06:49 UTCEURACTIV
    HARVEST: Food safety hotspots

    The article discusses food safety issues focusing on PFAS, gene editing, and farm policy. It highlights these topics as current hotspots in the field of food safety.

  • POLITICSJun 9 · 05:28 UTCEURACTIV
    HARVEST: Budget’s shifting agendas

    The article discusses the budget's shifting agendas, focusing on gene editing, the Common Agricultural Policy (CAP), and enlargement topics.

  • SCIENCEJun 5 · 04:28 UTCSEATTLE TIMES
    In a first, scientists precisely edit human embryo genes

    Scientists have precisely edited human embryo genes for the first time, a development that has sparked serious debate for over a decade following the invention of CRISPR.

  • SCIENCEMay 26 · 09:00 UTCNEW SCIENTIST
    Will lab-grown sperm let infertile men have children of their own?

    A start-up claims to grow sperm in the lab for men who do not produce sperm, potentially offering a solution for infertility. Columnist Michael Le Page suggests this technique may need to be combined with gene editing to assist many men.

  • HEALTHApr 21 · 00:00 UTCNATURE NEWS
    Personalized CRISPR therapies could soon reach thousands — here’s how

    A new approach to trialing CRISPR therapies for rare genetic diseases could make their production economically viable, potentially enabling treatment for thousands. The study, published in Nature, highlights advancements in personalized medicine for genetic disorders.

  • HEALTHApr 10 · 14:12 UTCSCIENCE DAILY
    Scientists say we’ve been treating Alzheimer’s all wrong

    Alzheimer’s is being redefined as a complex interplay of biology, aging, and health rather than a single disease. Traditional single-target drugs have failed, prompting scientists to explore multi-pronged strategies like gene editing and gut health interventions.

gene editing · Dossier · The Nexus